Lexicon Pharmaceuticals, Inc. Made Headway
Tue, Nov 17, 2020 at 05:30 PM
Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ) shot up at $1.81, representing a gain of 40.3%. On Mon 16 Nov 20, LXRX:NASDAQ touched a New 2-Week High of $1.29. The stock appeared on our News Catalysts scanner on Mon 16 Nov 20 at 10:54 AM in the 'MISCELLANEOUS' category. From Mon 02 Nov 20, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Tue 21 Jul 20 at $2.89 with a volume of 23M+, and its share price has been moving sideways in recent weeks.
About Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ)
Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.
Top 10 Gainers:
- Phoenix Tree Holdings Limited (DNK:NYSE), 75.18%
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 49.55%
- Riot Blockchain, Inc. (RIOT:NASDAQ), 48.41%
- Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ), 40.31%
- Gannett Co., Inc. (GCI:NYSE), 32.76%
- Miragen Therapeutics (MGEN:NASDAQ), 32.23%
- Nxt-ID, Inc. (NXTD:NASDAQ), 29.89%
- Net Element, Inc. (NETE:NASDAQ), 25.03%
- Marathon Patent Group, Inc. (MARA:NASDAQ), 25%
- Evogene Ltd. (EVGN:NASDAQ), 24.48%